Vault-13

WUXI BIOLOGICS CAYMAN INC USD00000083 144A REG S WXIBF

COM · Common Stock · CUSIP G97008117

1 institutional holders +0 vs Q1 2021
9,139,3989.1m shares reported held*
$167.5mreported value*
0 new 0 added 1 reduced 0 sold out net sold ≈ $1.8m (-97.5k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $18.32.

Trends to Q2 2021

Institutional holders

Managers reporting a position, each quarter

001Q4 20: 1Q1 21: 1Q2 21: 11Q4 20Q1 21Q2 21
Numbers
QuarterHolders
Q4 20201
Q1 20211
Q2 20211

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q1 21: 1 bought or addedQ1 21: 0 cut or sold outQ1 21Q2 21: 0 bought or addedQ2 21: 1 cut or sold outQ2 21
Numbers
QuarterBought or addedCut or sold out
Q1 202110
Q2 202101

Biggest buyers

None

Biggest sellers

GILDER GAGNON HOWE & CO LLC Reduced -97,471-97.5k

Holders, Q2 2021

#ManagerLocationShares Value% of their portfolioChangeShares change
1 GILDER GAGNON HOWE & CO LLC 0.82% of their portfolio New York, NY 9,139,3989.1m $167.5m $167.5m 0.82% Reduced -97.5k -97,471